3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Etoposide
6
Radiotherapy
4
Cisplatin
3
Docetaxel
2
Carboplatin
2
venetoclax
1
trametinib
1
toripalimab
1
tislelizumab
1
talazoparib
1
sacituzumab govitecan
1
rovalpituzumab tesirine
1
regorafenib
1
poly ICLC
1
pembrolizumab
1
olaparib
1
obatoclax
1
nintedanib
1
fludarabine phosphate
1
etoposide phosphate
1
enoxaparin sodium
1
durvalumab
1
alpha-Tocopherol
1
Vitamin E
1
Topotecan
1
Tomography, Optical Coherence
1
Thymalfasin
1
Taxes
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Small Cell Lung Carcinoma
×
DOXO-EMCH
×
Clear all
NCT00472771
2012-02-09
INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
CytRx
Phase 2
Withdrawn